Gupta N, Gupta A, Narayanan M R V. Current status of nitrous oxide use in pediatric patients. World J Clin Pediatr 2022; 11(2): 93-104 [PMID: 35433304 DOI: 10.5409/wjcp.v11.i2.93]
Corresponding Author of This Article
Anju Gupta, MD, Assistant Professor, Department of Anesthesiology, Pain Medicine and Critical Care, AIIMS, Room No. 6, Porta Cabin, Fourth floor teaching block, New Delhi 110029, Delhi, India. dranjugupta2009@rediffmail.com
Research Domain of This Article
Anesthesiology
Article-Type of This Article
Opinion Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Risk of death at 1 year, cardiovascular complications (combined RR for death and cardiovascular complications was 0.96, 95%CI: 0.83-1.12; P = 0.64) or surgical-site infection in the nitrous oxide group not increased (P = 0.61). Risk of PONV was reduced by one third in the patients not exposed to nitrous oxide (P < 0.0001), but the absolute risk reduction was only 4%.
Patients receiving nitrous oxide had 40% lower risk of pulmonary complication (OR: 95% Bonferroni-adjusted CI: 0.59, 0.44-0.78) and death (OR: 97.5%CI: 0.67, 0.46-0.97; P = 0.02), while cardiovascular complications were comparable.
Cochrane review on complications with use of nitrous oxide
Nitrous oxide increased the incidence of pulmonary atelectasis (OR: 1.57, 95%CI: 1.18-2.10, P = 0.002) but had no effects on the rates of in-hospital mortality, pneumonia, myocardial infarction, stroke, venous thromboembolism, wound infection, or length of hospital stay.
Cochrane review on accidental awareness with use of nitrous oxide
Despite the inclusion of 3520 participants, only three awareness events were reported by two studies. In one study the event was due to technical failure. Due to the low quality of evidence, the authors could not determine whether the use of nitrous oxide in general anesthesia increases, decreases, or has no effect on the risk of accidental awareness.
Table 4 Summary of various trials on use of nitrous oxide for alleviation of procedural pain and sedation in children
To find out whether oral midazolam or 50% N2O, or 10% N2O; along with lidocaine/prilocaine ointment is most effective in gaining IV access in obese or growth retarded children
Children and adolescents undergoing IV access at a Children’s Hospital in Stockholm, Sweden
90; 5-18yr
50% N2O resulted in an improved rate of IV access, a shorter procedure time, and a better experience for these children
Determine the effectiveness and safety of procedural sedation performed using ketamine (0.5-1 mg/kg) or N2O (50%-70%).
Retrospective review and analysis of a quality improvement database for procedural sedations performed at St Louis Children’s Hospital undergoing sedation by pediatric hospitalists
8870; 7 mo to 4 yr
Combination of ketamine and N2O provides lowest rates of complications. Respiratory and cardiovascular events occurred more frequently with ketamine, whereas NV, sedation level not achieved, and procedure not completed were more frequent with N2O
Citation: Gupta N, Gupta A, Narayanan M R V. Current status of nitrous oxide use in pediatric patients. World J Clin Pediatr 2022; 11(2): 93-104